Manziana, Italy

Bruno Botta

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Università Degli Studi Di Roma "La Sapienza", Consiglio Nazionale Delle Ricerche, Fondazione Istituto Italiano Di Tecnologia. Active years: 1991-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Botta. Retrieved from https://idiyas.com/inventor/bruno-botta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Rome, IT (2018)
  • Manziana, IT (1991 - 2021)

Company Filing History:


Years Active: 1991-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Bruno Botta: Innovator in Cancer Treatment

Introduction

Bruno Botta is a notable inventor based in Manziana, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. With a total of 3 patents, his work focuses on addressing critical health challenges, particularly in oncology.

Latest Patents

Bruno Botta's latest patents include groundbreaking inventions aimed at treating T-cell acute lymphoblastic leukemia (T-ALL). One of his notable patents is for "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia," which involves compounds that exhibit anti-tumor activity. Another significant invention is related to "Multitarget hedgehog pathway inhibitors and uses thereof," which concerns compounds that selectively inhibit the Hedgehog (Hh) pathway, proving useful in treating Hh-dependent tumors such as medulloblastoma.

Career Highlights

Throughout his career, Bruno Botta has worked with prestigious institutions, including the University of Rome "La Sapienza" and the National Research Council of Italy. His research has been pivotal in advancing the understanding and treatment of various cancers, showcasing his dedication to improving patient outcomes.

Collaborations

Bruno has collaborated with esteemed colleagues, including Cinzia Ingallina and Mattia Mori. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries in cancer treatment.

Conclusion

Bruno Botta's contributions to cancer research and treatment through his patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to inspire advancements in therapeutic strategies for challenging diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…